Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9.

2.
3.

The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Kroeger KM, Carville KS, Abraham LJ.

Mol Immunol. 1997 Apr;34(5):391-9.

PMID:
9293772
4.

Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation.

Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL.

J Inflamm. 1995-1996;46(1):32-41.

PMID:
8832970
5.

Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.

Aidoo M, McElroy PD, Kolczak MS, Terlouw DJ, ter Kuile FO, Nahlen B, Lal AA, Udhayakumar V.

Genet Epidemiol. 2001 Nov;21(3):201-11.

PMID:
11668577
6.

[Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].

Aguillón JC, Cruzat A, Cuenca J, Cuchacovich M.

Rev Med Chil. 2002 Sep;130(9):1043-50. Review. Spanish.

PMID:
12434654
7.

TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.

McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D.

Eur J Immunol. 1996 Sep;26(9):2113-8.

PMID:
8814255
8.

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW.

J Exp Med. 1993 Feb 1;177(2):557-60.

9.
10.

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW; European Study Group of Primary Sclerosing Cholangitis..

Gut. 2001 Aug;49(2):288-94.

11.

Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism.

Kroeger KM, Steer JH, Joyce DA, Abraham LJ.

Cytokine. 2000 Feb;12(2):110-9.

PMID:
10671295
12.

Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis.

Zhang D, Li J, Jiang ZW, Yu B, Tang X.

J Surg Res. 2003 Jun 15;112(2):138-43.

PMID:
12888330
13.
14.

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D.

Nature. 1994 Oct 6;371(6497):508-10.

PMID:
7935762
15.
16.
17.

Promoter region polymorphism in the human TNF-alpha gene is not associated with lichen sclerosus.

Clay FE, Cork MJ, Wilson AG, Crane AM, Lewis F, Harrington CI, Duff GW.

Exp Dermatol. 1996 Aug;5(4):227-9.

PMID:
8889470
18.

Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.

Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR.

Cancer Causes Control. 2004 Sep;15(7):657-63.

PMID:
15280623
19.

Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis.

Messer G, Kick G, Ranki A, Koskimies S, Reunala T, Meurer M.

Dermatology. 1994;189 Suppl 1:135-7.

PMID:
7914110
20.

-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter.

Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA.

J Inflamm. 1995-1996;46(1):42-50.

PMID:
8832971
Items per page

Supplemental Content

Support Center